The central finding of this study is that COVID-19 infection exacerbates the extracorporeal coagulation level of CKD patients in a symptom’s severity-dependent manner, especially in the patients with severe/critical symptoms, and that this blood hypercoagulable state is associated with the upregulation of vWF/FBLN5 signaling. The gene discussed is FBLN5; the disease is thrombophilia.